tiprankstipranks
Eledon Pharmaceuticals, Inc. (ELDN)
:ELDN
US Market

Eledon Pharmaceuticals (ELDN) Income Statement

Compare
811 Followers

Eledon Pharmaceuticals Income Statement

Last quarter (Q3 2024), Eledon Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Eledon Pharmaceuticals's net income was $76.97M. See Eledon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 120.00K$ 0.00
Gross Profit
$ -374.00K$ -373.00K$ -195.00K$ -63.00K$ -182.00K
Operating Expenses
$ 43.00M$ 39.78M$ 36.87M$ 16.18M$ 14.18M
Depreciation and Amortization
$ 43.00M$ 373.00K$ 195.00K$ 183.00K$ 182.00K
EBITDA
$ 0.00$ -87.59M$ -36.66M$ -23.03M$ -15.83M
Operating Income
$ -43.00M$ 8.49M$ -36.87M$ -18.46M$ -16.05M
Other Income/Expenses
$ 2.67M$ 462.00K$ 7.00K$ -4.75M$ 40.00K
Pretax Income
$ -40.33M$ -87.97M$ -36.86M$ -23.21M$ -16.01M
Net Income
$ -40.33M$ -87.50M$ -34.51M$ -22.81M$ -17.88M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ -6.13$ -2.33$ -15.72$ -27.27
Diluted EPS
$ -1.64$ -6.13$ -2.33$ -15.72$ -27.27
Weighted Average Shares Outstanding
24.62B 14.29M 14.82M 1.45M 655.52K
Weighted Average Shares Outstanding (Diluted)
24.62M 14.29M 14.82M 1.45M 655.52K
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis